Brief: Agile Therapeutics Reports Q2 2021 Financial Results
26/07/2021 21:19
July 26 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $0.20
* SAYS CONTINUES TO PROGRESS ON EXPANDING ACCESS TO TWIRLA
* Q2 REVENUE $1.2 MILLION
Source text for Eikon: ID:nGNX9BTln8
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt